Welcome to LookChem.com Sign In|Join Free

CAS

  • or
3-Aminocyclopentanecarboxylic acid hydrochloride is an amino acid derivative that is widely utilized in pharmaceutical research and development. It is known for its diverse biological activities, such as inhibiting the alanine aminotransferase enzyme, and has been studied for its potential to reduce oxidative stress and inflammation within the body. This chemical compound serves as a valuable building block in the synthesis of innovative pharmaceutical drugs, making it an essential tool in drug discovery and medicinal chemistry research.

1203306-05-1

Post Buying Request

1203306-05-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 3-AMinocyclopentanecarboxylic acid hydrochloride;Cyclopentanecarboxylic acid, 3-aMino-, hydrochloride

    Cas No: 1203306-05-1

  • No Data

  • No Data

  • No Data

  • LEAP CHEM Co., Ltd.
  • Contact Supplier

1203306-05-1 Usage

Uses

Used in Pharmaceutical Research and Development:
3-Aminocyclopentanecarboxylic acid hydrochloride is used as a building block for the synthesis of novel pharmaceutical drugs due to its diverse biological activities and potential therapeutic applications.
Used in Inhibition of Alanine Aminotransferase:
In the pharmaceutical industry, 3-Aminocyclopentanecarboxylic acid hydrochloride is used as an inhibitor of the alanine aminotransferase enzyme, which plays a crucial role in the metabolism of amino acids and has implications in various diseases.
Used in Reducing Oxidative Stress and Inflammation:
3-Aminocyclopentanecarboxylic acid hydrochloride is employed as a potential agent for reducing oxidative stress and inflammation in the body, which are common factors in numerous pathological conditions.
Used in Drug Discovery and Medicinal Chemistry Research:
As a valuable tool in drug discovery and medicinal chemistry, 3-Aminocyclopentanecarboxylic acid hydrochloride aids researchers in identifying new drug candidates and understanding the mechanisms of action for existing pharmaceuticals.

Check Digit Verification of cas no

The CAS Registry Mumber 1203306-05-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,0,3,3,0 and 6 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1203306-05:
(9*1)+(8*2)+(7*0)+(6*3)+(5*3)+(4*0)+(3*6)+(2*0)+(1*5)=81
81 % 10 = 1
So 1203306-05-1 is a valid CAS Registry Number.

1203306-05-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-Aminocyclopentanecarboxylic acid hydrochloride

1.2 Other means of identification

Product number -
Other names 3-aminocyclopentane-1-carboxylic acid,hydrochloride

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1203306-05-1 SDS

1203306-05-1Relevant articles and documents

Design and Mechanism of Tetrahydrothiophene-Based γ-Aminobutyric Acid Aminotransferase Inactivators

Le, Hoang V.,Hawker, Dustin D.,Wu, Rui,Doud, Emma,Widom, Julia,Sanishvili, Ruslan,Liu, Dali,Kelleher, Neil L.,Silverman, Richard B.

, p. 4525 - 4533 (2015)

Low levels of γ-aminobutyric acid (GABA), one of two major neurotransmitters that regulate brain neuronal activity, are associated with many neurological disorders, such as epilepsy, Parkinson's disease, Alzheimer's disease, Huntington's disease, and cocaine addiction. One of the main methods to raise the GABA level in human brain is to use small molecules that cross the blood-brain barrier and inhibit the activity of γ-aminobutyric acid aminotransferase (GABA-AT), the enzyme that degrades GABA. We have designed a series of conformationally restricted tetrahydrothiophene-based GABA analogues with a properly positioned leaving group that could facilitate a ring-opening mechanism, leading to inactivation of GABA-AT. One compound in the series is 8 times more efficient an inactivator of GABA-AT than vigabatrin, the only FDA-approved inactivator of GABA-AT. Our mechanistic studies show that the compound inactivates GABA-AT by a new mechanism. The metabolite resulting from inactivation does not covalently bind to amino acid residues of GABA-AT but stays in the active site via H-bonding interactions with Arg-192, a π-π interaction with Phe-189, and a weak nonbonded S......O=C interaction with Glu-270, thereby inactivating the enzyme. (Figure Presented).

Divergent Synthesis of γ-Amino Acid and γ-Lactam Derivatives from meso-Glutaric Anhydrides

Connon, Stephen J.,Craig, Ryan,Smith, Simon N.

supporting information, p. 13378 - 13382 (2020/10/02)

The first divergent synthesis of both γ-amino acid and γ-lactam derivatives from meso-glutaric anhydrides is described. The organocatalytic desymmetrisation with TMSN3 relies on controlled generation of a nucleophilic ammonium azide species mediated by a polystyrene-bound base to promote efficient silylazidation. After Curtius rearrangement of the acyl azide intermediate to access the corresponding isocyanate, hydrolysis/alcoholysis provided uniformly high yields of γ-amino acids and their N-protected counterparts. The same intermediates were shown to undergo an unprecedented decarboxylation–cyclisation cascade in situ to provide synthetically useful yields of γ-lactam derivatives without using any further activating agents. Mechanistic insights invoke the intermediacy of an unconventional γ-N-carboxyanhydride (γ-NCA) in the latter process. Among the examples prepared using this transformation are 8 APIs/molecules of considerable medicinal interest.

PYRAZOLO-PYRIMIDIN-AMINO-CYCLOALKYL COMPOUNDS AND THEIR THERAPEUTIC USES

-

Paragraph 0529, (2019/12/28)

Disclosed herein are pyrazolo-pyrimid in-ami no-cycloalkyl compounds, analogs thereof, pharmaceutical compositions comprising thereof and therapeutic uses therefor.

Enhanced enzymatic synthesis of the enantiopure intermediate for the blockbuster drug intermediate abacavir through a two-step enzymatic cascade reaction

Galla, Zsolt,Forró, Enik?,Fül?p, Ferenc

, p. 729 - 731 (2016/08/01)

A very efficient enzymatic two-step cascade reaction was devised (E?>?200) for the resolution of activated γ-lactams (±)-1 and (±)-2. The N-hydroxymethyl group worked as a traceless activating group, when the reactions were performed with H2O (0.5?equiv) in the presence of benzylamine (1?equiv) in i-Pr2O at 60?°C. The ring-opened enantiomerically pure γ-amino acids (1S,4R)-6 (ee?=?99%, intermediate of abacavir) and (1S,3R)-8 (ee?=?99%) and unreacted lactams (1S,4R)-1 and (1R,4S)-2 (ee???96%) were obtained in good yields (?43%). Treatment of (1S,4R)-1 and (1R,4S)-2 with 18% HCl or NH4OH resulted in (1R,4S)-6·HCl and (1S,3R)-8·HCl or (1S,4R)-3 and (1R,4S)-4 quantitatively, with ee???96%.

TETRAHYDROTHIOPHENE-BASED GABA AMINOTRANSFERASE INACTIVATORS

-

, (2016/09/26)

Tetrahydrothiophene and related heterocyclic analogs and related methods for GABA aminotransferase inactivation.

1,3-DISUBSTITUTED CYCLOPENTANE DERIVATIVES

-

Page/Page column 58; 59, (2015/02/25)

Compounds of the formula (I) in which R, Y, R1, X1, X2, X3 and q have the meanings indicated in Claim 1, are inhibitors of fatty acid synthase, and can be employed, inter alia, for the treatment of diseases such as cancer, cardiovascular diseases, central nervous system injury and different forms of inflammation.

Synthesis of cyclic γ-amino acids for foldamers and peptide nanotubes

Rodriguez-Vazquez, Nuria,Salzinger, Stephan,Silva, Luis F.,Amorin, Manuel,Granja, Juan R.

, p. 3477 - 3493 (2013/07/11)

Cyclic γ-amino acids are molecular building blocks of great interest in peptide and foldamer chemistry, as they allow the preparation of new structures that are not found in Nature. In this paper, we describe the synthesis of cyclic γ-amino acids that have a cis relationship between the amino and the carboxylic acid groups. This arrangement, in most cases, induces the resulting peptides to adopt a flat conformation, which makes them appropriate for the design of foldamers that adopt β-sheet-type structures. We describe the synthesis of cyclic γ-amino acids that have a cis relationship between the amino and the carboxylic acid groups. This makes them suitable for the design of foldamers that adopt β-sheet-type structures.

Inhibitors of protein kinases

-

, (2011/10/04)

Compounds of general Formula (I): wherein R1, R2, R3, Ra, A, B and x are as defined herein are inhibitors of protein kinases in particular members of the cyclin-dependent kinase family and/or the glycogen synthase kinase 3 family and are useful in preventing and/or treating any type of pain, inflammatory disorders, cancer, immunological diseases, proliferative diseases, infectious diseases, cardiovascular diseases, metabolic disorders, renal diseases, neurologic and neuropsychiatric diseases and neurodegenerative diseases.

Enzymatic method for the synthesis of blockbuster drug intermediates - Synthesis of five-membered cyclic γ-amino acid and γ-lactam enantiomers

Forro, Eniko,Fueloep, Ferenc

experimental part, p. 5263 - 5268 (2009/06/18)

A very efficient enzymatic method was developed for the synthesis of cyclic γ-lactam and γ-amino acid enantiomers, intermediates for drugs with a prominent turnover (e.g., abacavir and carbovir), through the CAL-B-catalysed enantioselective (E > 200) hydrolysis of the corresponding N-Boc protected and unprotected racemic γ-lactams with H2O in iPr2O. Wiley-VCH Verlag GmbH & Co. KGaA, 2008.

Methyl-blocked dimeric α,γ-peptide nanotube segments: Formation of a peptide heterodimer through backbone-backbone interactions

Brea, Roberto J.,Amorin, Manuel,Castedo, Luis,Granja, Juan R.

, p. 5710 - 5713 (2007/10/03)

Cyclic peptides can dimerize through β-sheet-like hydrogen bonding. Heterodimerization is favored over homodimerization, which creates interesting combinatorial possibilities without detriment to the functionalization of amino acid side chains. These dime

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1203306-05-1